Full text is available at the source.
Akkermansia muciniphila in Central Nervous System Disorders: Mechanisms, Controversies, and Therapeutic Potential
The Role of Akkermansia muciniphila Bacteria in Brain and Nervous System Disorders: How It Works, Debates, and Possible Treatments
AI simplified
Abstract
Akkermansia muciniphila is involved in central nervous system disorders and has both beneficial and controversial effects.
- A. muciniphila may play a role in metabolic diseases such as obesity and diabetes.
- The bacterium is associated with both neuroprotection and pathogenesis in CNS disorders.
- Key mechanisms include immunomodulation, metabolic regulation, and reinforcement of protective barriers.
- While it shows potential benefits for Alzheimer's disease, stroke, and depression, its effects in multiple sclerosis and Parkinson's disease are complex and context-dependent.
- Further investigation is needed to clarify the causality of A. muciniphila's relationship with CNS disorders and its potential as a diagnostic biomarker or target for probiotics.
AI simplified